Sign up to create alerts for Instruments,
Economic Events and content by followed authors
Free Sign Up Already have an account? Sign In
Quotes
All Instrument Types
- All Instrument Types
- Indices
- Equities
- ETFs
- Funds
- Commodities
- Currencies
- Crypto
- Bonds
- Certificates
Please try another search
Free Webinar - Unlock Trading Opportunities with Interest Rates Thursday, January 19, 2023 | 01:00AM PST Enroll Now
Dr. Martens plunges after fresh profit warning
© Reuters
By Geoffrey Smith
Investing.com -- Dr. Martens (LON:DOCS) stock plunged at the open on Thursday to a new all-time low, after the bootmaker was forced to cut its forecasts once again in response to problems in North America.
Dr. Martens said a variety of operational problems had created a bottleneck at its new distribution center in Los Angeles, leaving U.S. sales well below expectations in the third quarter of its fiscal year. As a result, it now expects revenue to grow by around only 12%, rather than the "high teens" percentage it had forecast at the start of the year.
Likewise, it now expects earnings before interest, taxes, depreciation, and amortization to be between £250-260 million (£1 = $1.2315), reflecting a hit of between £16-25M to EBITDA from the problems in Los Angeles. The problems are likely to continue into the new fiscal year starting in April, but "should normalize" by October, it said.
Analysts had expected full-year EBITDA to be around £285M.
Ironically, the bottleneck at LA was caused by the easing of others elsewhere: inbound shipping times shortened significantly during the quarter, resulting in inventory arriving more quickly than anticipated. However, U.S. wholesalers reacting to signs of a consumer slowdown were unable to take the new inventory as quickly as the company had thought. A planned transfer of inventory from a distribution center in Portland also went faster than expected, leading to shoes piling up in LA instead.
Dr. Martens had already signaled in November that its direct-to-consumer business had been suffering as demand weakened but had nonetheless plowed ahead with heavy investment spending and raised its interim dividend.
In the three months through December, sales slowed further. Group revenue rose only 3% in constant currencies from a year earlier, but it was the wholesale business, rather than DTC, which fared worst, with sales actually down 1%.
Dr. Martens' stock fell as much as 28% initially but had recovered a little by 03:55 ET (08:55 GMT) to trade down "only" 21.2%.
Related Articles
Add Chart to Comment
Confirm Block
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
Report this comment
I feel that this comment is:
Comment flagged
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.